Immunometabolism and T Cell Metabolism
The trajectory
| State | Dominant substrate use | What is usually measured | Functional correlate |
|---|---|---|---|
| Naive | Oxidative; low flux | Spare respiratory capacity, basal OCR | Survival, readiness to respond |
| Activated effector | Glycolysis, glutamine, one-carbon | ECAR, lactate, glucose uptake | Clonal expansion, cytokine output |
| Memory | Fatty acid oxidation, mitochondrial spare capacity | OCR, FAO dependence, IL-15 culture | Recall response, persistence |
| Exhausted | Mixed; mitochondrial dysfunction described | OCR, mitochondrial membrane potential | Reduced polyfunctionality |
Important distinction. The table describes states established in defined culture systems. In tissue, a T cell occupies a position on a continuum that depends on antigen load, costimulation, oxygen, and the nutrients available at that site. A sorting panel that assigns "effector" and "memory" from surface markers is assigning a differentiation stage, and the metabolic programme can differ between two cells with the same markers.
Culture variables that decide the answer
| Variable | Typical culture value | Plasma value | Consequence |
|---|---|---|---|
| Glucose | 11 mM (RPMI 1640), 25 mM (DMEM) | ~5 mM | Effector expansion is measured under surplus glucose |
| Glutamine | 2 mM | ~0.5–0.7 mM | Glutaminolysis appears more important than it may be in vivo |
| Serum | 10% fetal bovine serum | — | Lipid and hormone content undefined and batch-variable |
| Oxygen | 18–21% | 3–8% in tissue | Oxidative metabolism is favoured by the incubator |
| Activation | Anti-CD3/CD28 beads | Antigen-presenting cell | Bead stimulation is stronger, more synchronous, and bypasses antigen processing |
The first row is the one that changes conclusions most. At 11 mM glucose, a cell that would be glycolytically limited at 5 mM is not, so a "glycolysis-dependent" phenotype can be a phenotype of surplus substrate. The same experiment at 5 mM may show either a stronger requirement or a different programme.
Caveat on serum. Fetal bovine serum supplies lipids, insulin-like activity, and undefined growth factors. A memory T cell cultured in 10% serum has access to fatty acids that a T cell in a tumour does not. Free-fatty-acid-free or delipidated serum is the control that is almost never run.
What "dependency" means here
For a T cell, the relevant currency is rarely ATP. A proliferating lymphocyte needs carbon for nucleotide and lipid synthesis, nitrogen for amino acids, and acetyl-CoA for histone acetylation.
| Claim | What it asserts | The experiment that supports it |
|---|---|---|
| Glycolysis supports effector function | Flux is required for effector programmes | Glucose restriction reduces IFN-γ and expansion, not necessarily viability |
| Glutamine supports differentiation | Nitrogen or carbon supply is limiting | Withdrawal reduces proliferation; α-KG or nucleotide rescue distinguishes the arm |
| FAO supports memory | Fatty acid oxidation maintains persistence | Etomoxir or CPT1a deletion reduces recall; interpret with the selectivity caveat |
| Mitochondrial spare capacity predicts persistence | A capacity, not a rate | FCCP-titrated maximal respiration; correlates with engraftment |
Important distinction. The first row is often stated as "effector T cells require glycolysis for ATP", which is the least likely mechanism. Effector T cells in culture have ample glucose and produce ATP readily; what restricts them when glucose is withdrawn is biosynthetic precursor supply and, in some settings, histone acetylation. The claim and the mechanism should be separated.
Caveat on etomoxir. Etomoxir is used to define FAO dependence in T cells, and above low micromolar concentrations it affects the adenine nucleotide translocator and CoA homeostasis. A memory defect produced at 200 µM is not evidence of CPT1a dependence; the genetic arm is.
The assays, and their limits
| Assay | Requires | Reports | Fails when |
|---|---|---|---|
| Seahorse extracellular flux | Adherent or immobilised cells; defined buffer | ECAR, OCR, derived parameters | Cell number is low, or the buffer starves the cells |
| SCENITH | Fixable; flow cytometry | Relative substrate dependence per cell | Requires careful gating and a translation inhibitor control |
| Glucose uptake (2-NBDG, flow) | Single-cell suspension | Relative uptake | Probe saturation; not a rate |
| ¹³C tracing | Enough cells for mass spectrometry | Route of substrate use | Cell numbers are usually limiting |
| Lactate/glucose in medium | Defined volume and window | Net exchange | Not per-cell without counting |
Readout note. T cells do not adhere, which breaks the usual Seahorse workflow and usually forces one of three compromises: Cell-Tak or Matrigel immobilisation, which changes the mechanical environment; very high cell numbers per well, which changes the local nutrient depletion; or suspension-adapted plates. Whichever is used, the assay medium lacks serum, bicarbonate and often glucose at culture concentration, so the measurement is of a cell that has been switched to a different medium an hour earlier.
Important distinction. SCENITH and Seahorse answer different questions. Seahorse gives flux per well for a population; SCENITH gives a relative dependence per cell by flow. For a heterogeneous population — which activated T cells always are — the population average hides the structure, and the single-cell method is the better match to the question.
Exhaustion is not "less glycolysis"
Exhausted T cells are a distinct transcriptional state, and their metabolic description is more complicated than a flux reduction.
- • Mitochondrial dysfunction is reported as reduced spare capacity and altered membrane potential, not simply reduced OCR.
- • Nutrient competition in the tumour microenvironment — glucose, arginine, tryptophan — suppresses function through mechanisms that are partly metabolic and partly signalling.
- • Persistent antigen drives the state; removing antigen does not fully reverse it, which is the operational definition of exhaustion as opposed to fatigue.
Caveat on tumour microenvironment claims. A tumour-associated T cell isolated by digestion has been exposed to dissociation stress, which induces immediate-early genes and heat shock responses within minutes. The "stressed" transcriptional signature may be partly a signature of the isolation.
Failures that recur
- • Seahorse ECAR reported as glycolytic rate without checking the respiratory contribution to acidification.
- • Polarisation markers read as in vivo states. M1 and M2 are stimulation conditions.
- • 2-DG used as a glycolysis-specific tool although it also depletes glycosylation precursors.
- • Supraphysiological glucose and glutamine used in the "dependency" experiment.
- • Cell number not reported per well, so flux values are not comparable between conditions.
- • Serum lot changed between experiments, moving the baseline.
- • Metabolic phenotype reported without a functional endpoint — expansion, cytokine output, killing.
Where this connects
- • Glucose pillar supplies the ECAR caveat and the uptake-measurement rules.
- • Amino acid pillar supplies the 2-DG and glutamine-rescue logic that this article applies to immune cells.
- • Disease pillar supplies the frame: an immunometabolic claim is about an activation state in a tissue, not about a polarisation protocol.
- • Operationally, the flux assay parameters are in the companion article on running Seahorse assays on T cells.
Scientific interpretation and experimental design
- • Report glucose and glutamine concentrations. They set the baseline dependence.
- • Separate the claim from the mechanism. "Required for effector function" is not "required for ATP".
- • Use genetic arms for FAO. Etomoxir is not CPT1a-specific at common concentrations.
- • Match the assay to the population. Population flux hides heterogeneity.
- • Check the assay medium. Flux is measured in a buffer, not in culture medium.
- • Always pair metabolism with function. Expansion, cytokine output or killing.
- • Beware dissociation signatures. Isolation induces stress programmes within minutes.
Selected references for further reading
- • O'Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nature Reviews Immunology. 2016;16:553–565.
- • Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017;169:570–586.
- • Argüello RJ, et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metabolism. 2020;32:1063–1075.
- • Divakaruni AS, et al. Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metabolism. 2018;28:490–503.
- • Vardhana SA, et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nature Immunology. 2020;21:1022–1033.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »